Analysts Are Bullish on These Healthcare Stocks: BABY, STML

By Austin Angelo

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Natus Medical Inc (NASDAQ: BABY) and Stemline Therapeutics Inc (NASDAQ: STML) with bullish sentiments.

Natus Medical Inc (NASDAQ: BABY)

In a report released today, Chris Lewis from Roth Capital reiterated a Buy rating on Natus Medical Inc (NASDAQ: BABY), with a price target of $41. The company’s shares opened today at $36.20.

Lewis observed:

“We attended BABY’s inaugural investor day yesterday held in New York City . Overall, while we continue to expect 2017 will be a transition year focused on Otometrics integration and working through Newborn headwinds, management’s newly unveiled financial goals, namely achieving $1 billion in sales and pre-tax operating margins of 22% by 2022, reaffirm our long-term bullish outlook for the company’s growth and profitability prospects over the coming years.”

According to TipRanks.com, Lewis is a 4-star analyst with an average return of 6.3% and a 54.0% success rate. Lewis covers the Healthcare sector, focusing on stocks such as Cogentix Medical Inc, Trinity Biotech Plc, and Lemaitre Vascular.

Natus Medical Inc has an analyst consensus of Moderate Buy, with a price target consensus of $41.

Stemline Therapeutics Inc (NASDAQ: STML)

In a report released today, Boris Peaker from Cowen & Co. reiterated a Buy rating on Stemline Therapeutics Inc (NASDAQ: STML). The company’s shares opened today at $8.50.

Peaker noted:

“STML presented updated data for SL-401 in BPDCN.”

According to TipRanks.com, Peaker is a 3-star analyst with an average return of 2.4% and a 42.5% success rate. Peaker covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals Inc, Corvus Pharmaceuticals Inc, and Merrimack Pharmaceuticals.

Stemline Therapeutics Inc has an analyst consensus of Strong Buy, with a price target consensus of $25.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.